In one paragraphArticle in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Madeline MellettDepartment of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-1318-553X Julia Van RielDivision of Infectious Diseases, Department of Medicine, Emory School of Medicine, Atlanta, Georgia, USA.
Rachel CorsiniResearch Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Sarah SatolaDivision of Infectious Diseases, Department of Medicine, Emory School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-3059-0342 Alexander LawandiDepartment of Critical Care Medicine, McGill University Health Centre, Montreal, Quebec, Canada.ORCID 0000-0001-7948-3161 Chelsea CayaResearch Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Sebastiaan J van HalDepartment of Infectious Diseases and Microbiology, NSW Health Pathology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Todd C LeeDepartment of Critical Care Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Cedric P YansouniDivisions of Infectious Diseases and Medical Microbiology, McGill University Health Centre, Montreal, Quebec, Canada.ORCID 0000-0002-4765-3469 Ahmed BabikerDivision of Infectious Diseases, Department of Medicine, Emory School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0003-0578-4871 Matthew P ChengResearch Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Funding
Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8MNational Institute of Allergy and Infectious Diseases UM1AI104681NIAID NIH HHS UM1 AI104681
6 · The paper itselfAbstract
Antimicrobial combinations resulting in synergy against
Indexed as
Anti-Bacterial AgentsCefazolinClindamycinLinezolidStaphylococcus aureusDrug SynergismHumansMicrobial Sensitivity TestsStaphylococcal InfectionsAnti-Bacterial AgentsCefazolinClindamycinLinezolidMSSAStaphylococcus aureussynergy
Identifiers
PMID41025660
PMCPMC12584723
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390